Domov › Nemalobunkový karcinóm pľúc › Wisconsin › Madison
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Madison, WI
16 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Madison a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Prebieha náborFáza 3
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0129), Madison
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- University of Wisconsin Carbone Cancer Center, Madison
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- Local Institution - 0135, Madison
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Prebieha náborFáza 1
- Wisconsin Institute for Medical Research, Madison
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- University Hospital and UW Health Clinics, Madison
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Prebieha náborFáza 1/2
- UW Health Carbone Cancer Center, Madison
HEARTS Trial for Thoracic Cancers
Prebieha náborFáza 2
- University of Wisconsin - Madison, Madison
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Prebieha náborFáza 1/2
- The Board of Regents of the University of Wisconsin, Madison
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- University of Wisconsin - Carbone Cancer Center, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Wisconsin- Madison, Madison
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Prebieha náborFáza 1
- University of Wisconsin (Carbone Cancer Center), Madison
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Prebieha náborFáza 2
- Univeristy of Wisconsin, Madison
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Arlington, VA104 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
Iné štúdie v Madison
- Rakovina prostaty29 štúdií
- Kolorektálny karcinóm23 štúdií
- Rakovina prsníka22 štúdií
- Metastatická rakovina21 štúdií
- Akútna myeloidná leukémia16 štúdií
- Melanóm15 štúdií
- Rakovina (všetky typy)14 štúdií
- Rakovina vaječníkov13 štúdií
- Rakovina žalúdka11 štúdií
- Rakovina pankreasu10 štúdií
- Rakovina pľúc10 štúdií
- Mnohonásobný myelóm9 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.